Net Medical Stock Price, News & Analysis
Company Description
Net Medical (OTC Link: NMXS) is a publicly traded health information services company in the Healthcare sector. The company has a market capitalization of $3.8K.
NMXS stock has declined 94.3% over the past year. Shares last traded at $0.0005.
This page provides a comprehensive overview of NMXS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Net Medical (NMXS) stock last traded at $0.0005. Over the past 12 months, the stock has lost 94.3%. At a market capitalization of $3.8K, NMXS is classified as a micro-cap stock with approximately 37.7M shares outstanding.
Latest News
Net Medical has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include partnership, covid-19, earnings. View all NMXS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Net Medical (NMXS) currently stands at 4.9 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Net Medical (NMXS) currently stands at 4.9 days, down 96.4% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 96.4% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 4.9 to 137.1 days.
NMXS Company Profile & Sector Positioning
Net Medical (NMXS) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing NMXS often look at related companies in the same sector, including Uphealth Inc (UPHL), Babylon Hldgs Ltd (BBLNF), Cognetivity Neur (CGNSF), Healthtech Solutions Inc (HLTT), and Founders Hld (FDBH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NMXS's relative position within its industry.